Bessemer Group Inc Ionis Pharmaceuticals Inc Transaction History

Bessemer Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$33.58 - $41.2 $906 - $1,112	27 Added 108.0%	52 $2,000
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $927 - $1,163	25 New	25 $1,000
Q2 2022 Aug 10, 2022	SELL	$31.71 - $43.0 $28,539 - $38,700	-900 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $4,455 - $6,095	-129 Reduced 12.54%	900 $36,000
Q1 2021 May 13, 2021	BUY	$42.51 - $63.78 $5,483 - $8,227	129 Added 14.33%	1,029 $46,000
Q4 2019 Feb 04, 2020	SELL	$53.85 - $65.27 $2,692 - $3,263	-50 Reduced 5.26%	900 $54,000
Q2 2019 Jul 19, 2019	BUY	$62.09 - $86.14 $3,104 - $4,307	50 Added 5.56%	950 $61,000
Q1 2018 May 10, 2018	SELL	$44.08 - $55.05 $15,075 - $18,827	-342 Reduced 27.54%	900 $40,000
Q3 2017 Nov 03, 2017	BUY	$45.56 - $59.57 $56,585 - $73,985	1,242	1,242 $63,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

Stay updated on Bessemer Group Inc with notifications on news.